Literature DB >> 12124613

Neurodegenerative disease: amyloid pores from pathogenic mutations.

Hilal A Lashuel1, Dean Hartley, Benjamin M Petre, Thomas Walz, Peter T Lansbury.   

Abstract

Alzheimer's and Parkinson's diseases are associated with the formation in the brain of amyloid fibrils from beta-amyloid and alpha-synuclein proteins, respectively. It is likely that oligomeric fibrillization intermediates (protofibrils), rather than the fibrils themselves, are pathogenic, but the mechanism by which they cause neuronal death remains a mystery. We show here that mutant amyloid proteins associated with familial Alzheimer's and Parkinson's diseases form morphologically indistinguishable annular protofibrils that resemble a class of pore-forming bacterial toxins, suggesting that inappropriate membrane permeabilization might be the cause of cell dysfunction and even cell death in amyloid diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12124613     DOI: 10.1038/418291a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  422 in total

1.  Mutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerization.

Authors:  Judith Eschbach; Björn von Einem; Kathrin Müller; Hanna Bayer; Annika Scheffold; Bradley E Morrison; K Lenhard Rudolph; Dietmar R Thal; Anke Witting; Patrick Weydt; Markus Otto; Michael Fauler; Birgit Liss; Pamela J McLean; Albert R La Spada; Albert C Ludolph; Jochen H Weishaupt; Karin M Danzer
Journal:  Ann Neurol       Date:  2014-12-19       Impact factor: 10.422

2.  Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimer's disease research.

Authors:  Asad Jan; Dean M Hartley; Hilal A Lashuel
Journal:  Nat Protoc       Date:  2010-06-03       Impact factor: 13.491

3.  Atomic view of a toxic amyloid small oligomer.

Authors:  Arthur Laganowsky; Cong Liu; Michael R Sawaya; Julian P Whitelegge; Jiyong Park; Minglei Zhao; Anna Pensalfini; Angela B Soriaga; Meytal Landau; Poh K Teng; Duilio Cascio; Charles Glabe; David Eisenberg
Journal:  Science       Date:  2012-03-09       Impact factor: 47.728

Review 4.  Etiology of Parkinson's disease: Genetics and environment revisited.

Authors:  Kathy Steece-Collier; Eleonora Maries; Jeffrey H Kordower
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

5.  Unraveling the secrets of Alzheimer's beta-amyloid fibrils.

Authors:  Lynmarie K Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-13       Impact factor: 11.205

Review 6.  Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies.

Authors:  Elvira Valera; Eliezer Masliah
Journal:  Pharmacol Ther       Date:  2013-02-04       Impact factor: 12.310

7.  Expression and purification of amyloid-beta peptides from Escherichia coli.

Authors:  Kanchan Garai; Scott L Crick; Sourajit M Mustafi; Carl Frieden
Journal:  Protein Expr Purif       Date:  2009-02-20       Impact factor: 1.650

8.  Quantification of alpha-synuclein binding to lipid vesicles using fluorescence correlation spectroscopy.

Authors:  Elizabeth Rhoades; Trudy F Ramlall; Watt W Webb; David Eliezer
Journal:  Biophys J       Date:  2006-03-31       Impact factor: 4.033

9.  Genetic evidence linking age-dependent attenuation of the 26S proteasome with the aging process.

Authors:  Ayako Tonoki; Erina Kuranaga; Takeyasu Tomioka; Jun Hamazaki; Shigeo Murata; Keiji Tanaka; Masayuki Miura
Journal:  Mol Cell Biol       Date:  2008-12-15       Impact factor: 4.272

10.  Structures and dynamics of β-barrel oligomer intermediates of amyloid-beta16-22 aggregation.

Authors:  Xinwei Ge; Yunxiang Sun; Feng Ding
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-03-14       Impact factor: 3.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.